Wuhan Neurophth Biotechnology Limited Company

This study is testing a one-time gene therapy injection into the eye to see if it can improve vision in people with a specific genetic form of Leber's hereditary optic neuropathy (LHON), which causes severe vision loss. It will involve about 95 participants, aged 12 to 75, who ha…